The Current State of Patient Adherence to Lab Monitoring Guidelines for Janus Kinase Inhibitors in Patients with Alopecia Areata
June 2025
in “
PubMed
”
New to Alopecia Areata? There is a guide in the encyclopedia. Read the guide → Studysummary This study concluded that patients with alopecia areata receiving Janus kinase inhibitors are not maintaining the recommended frequency of lab monitoring every three months, indicating a need for new strategies to improve adherence. Our plain-language summary of this paper — not a Tressless recommendation.
The study analyzed adherence to lab monitoring guidelines for patients with alopecia areata (AA) using Janus kinase inhibitors (JAKi) at a specialty hair clinic. A retrospective chart review of 57 patients revealed that most were not adhering to the recommended lab monitoring frequency of every three months. Significant differences in blood test intervals were observed between adherent and non-adherent patients, with p-values less than 0.01. The conclusion emphasizes the need for new strategies to improve adherence to lab monitoring protocols for patients undergoing JAKi treatment.
